At Alcon, we believe that doing business with integrity drives performance through managing risks, strengthening our reputation and fostering competitive advantage. While the environment in which we conduct our business becomes increasingly complex and competitive, it is up to all of us to protect the integrity of our company, our associates and our customers by adhering to regulatory, legal and company standards.
As part of the Novartis family, Alcon is committed to maintaining the trust and support of key stakeholder groups: patients, associates, healthcare partners, shareholders and society. The Novartis Code of Conduct establishes the fundamental rules and principles of ethical business conduct, and reflects our commitment to good corporate citizenship.
Alcon follows the Novartis Anti-Bribery and Corruption Policies. Novartis Group companies will not engage directly or indirectly in bribery. Bribery means to offer, promise or provide an undue benefit to a public official with the intention of obtaining or retaining an improper advantage by encouraging the official to act, or refrain from acting, in connection with an official duty. All activities of this nature are prohibited.
Alcon is committed to building and maintaining a culture of integrity. We actively encourage associates to report actual or suspected violations of our Code of Conduct, but realize that fear of reprisals can make people hesitant to speak up. This is why we enforce clear policies to prevent retaliation against any associate reporting an issue.
The Business Practices Office (BPO) offers employees and people outside of Alcon a channel through which to report misconduct. The BPO manages investigations into all complaints, and escalates any substantiated cases of misconduct to management for appropriate action.